SPMIP9
gene geneOn this page
Also known as FLJ25369TSC21
Summary
SPMIP9 (sperm microtubule inner protein 9, HGNC:26341) is a protein-coding gene on chromosome 2p11.2, encoding Protein SPMIP9 (Q96LM6). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in flagella axoneme.
Predicted to be involved in flagellated sperm motility. Located in cytoplasm.
Source: NCBI Gene 200523 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_152670
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26341 |
| Approved symbol | SPMIP9 |
| Name | sperm microtubule inner protein 9 |
| Location | 2p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25369, TSC21 |
| Ensembl gene | ENSG00000172073 |
| Ensembl biotype | protein_coding |
| OMIM | 619676 |
| Entrez | 200523 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000303254
RefSeq mRNA: 1 — MANE Select: NM_152670
NM_152670
CCDS: CCDS2003
Canonical transcript exons
ENST00000303254 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001144244 | 88529052 | 88529585 |
| ENSE00001144251 | 88525635 | 88525671 |
| ENSE00001158393 | 88526405 | 88526497 |
| ENSE00001158398 | 88524649 | 88524782 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 95.66.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1371 / max 121.3419, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21348 | 0.1371 | 3 |
Top tissues by expression
218 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 95.66 | gold quality |
| left testis | UBERON:0004533 | 94.58 | gold quality |
| testis | UBERON:0000473 | 91.14 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.16 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.38 | silver quality |
| sperm | CL:0000019 | 84.89 | silver quality |
| tibialis anterior | UBERON:0001385 | 83.26 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.59 | gold quality |
| kidney epithelium | UBERON:0004819 | 80.93 | gold quality |
| ileal mucosa | UBERON:0000331 | 76.83 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 74.80 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 73.63 | gold quality |
| upper arm skin | UBERON:0004263 | 71.03 | gold quality |
| secondary oocyte | CL:0000655 | 69.32 | silver quality |
| adult organism | UBERON:0007023 | 67.84 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 66.71 | gold quality |
| deltoid | UBERON:0001476 | 66.14 | gold quality |
| superficial temporal artery | UBERON:0001614 | 62.56 | gold quality |
| myocardium | UBERON:0002349 | 61.71 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 58.72 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.58 | gold quality |
| pylorus | UBERON:0001166 | 58.55 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 58.15 | gold quality |
| nipple | UBERON:0002030 | 58.12 | gold quality |
| quadriceps femoris | UBERON:0001377 | 57.99 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 57.92 | gold quality |
| saphenous vein | UBERON:0007318 | 57.79 | gold quality |
| pericardium | UBERON:0002407 | 57.68 | silver quality |
| renal medulla | UBERON:0000362 | 57.66 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 57.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.62 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting SPMIP9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-4793-3P | 94.87 | 65.85 | 896 |
Literature-anchored findings (GeneRIF, showing 1)
- Identification of a novel gene, Tsc21, exclusively expressed in testes. (PMID:17091336)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spmip9 | ENSMUSG00000051896 |
| rattus_norvegicus | Spmip9 | ENSRNOG00000006476 |
Protein
Protein identifiers
Protein SPMIP9 — Q96LM6 (reviewed: Q96LM6)
Alternative names: Sperm microtubule inner protein 9, Testis-expressed sequence 37 protein, Testis-specific conserved protein of 21 kDa
All UniProt accessions (2): Q96LM6, A0A140VK60
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in flagella axoneme.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Nucleus. Cytoplasm. Cytoskeleton. Flagellum axoneme.
Tissue specificity. Testis-specific. Detected in the germ cell lineage at all stages.
RefSeq proteins (1): NP_689883* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029361 | SPMIP9 | Family |
Pfam: PF15217
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LM6-F1 | 55.32 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
FXR_IR1_Q6, AREB6_03, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, chr2p11, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CYTOPLASMIC_MICROTUBULE, GOCC_CILIUM, TST1_01, MARTENS_TRETINOIN_RESPONSE_UP, GOCC_AXONEMAL_MICROTUBULE, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER
GO Biological Process (1): flagellated sperm motility (GO:0030317)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): nucleus (GO:0005634), cytoplasm (GO:0005737), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPMIP9 | TEX44 | Q53QW1 | 667 |
| SPMIP9 | TEX36 | Q5VZQ5 | 624 |
| SPMIP9 | TEX55 | Q96M34 | 585 |
| SPMIP9 | TEX35 | Q5T0J7 | 571 |
| SPMIP9 | THNSL2 | Q86YJ6 | 568 |
| SPMIP9 | TSC2 | P49815 | 558 |
| SPMIP9 | PRSS55 | Q6UWB4 | 539 |
| SPMIP9 | FOXI3 | A8MTJ6 | 515 |
| SPMIP9 | C5orf52 | A6NGY3 | 507 |
| SPMIP9 | CCDC116 | Q8IYX3 | 497 |
| SPMIP9 | SMYD1 | Q8NB12 | 481 |
| SPMIP9 | PRSS54 | Q6PEW0 | 479 |
| SPMIP9 | SPATA31E1 | Q6ZUB1 | 475 |
| SPMIP9 | CFAP97D1 | B2RV13 | 474 |
| SPMIP9 | LRRC72 | A6NJI9 | 447 |
IntAct
146 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DAZAP2 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TRIP13 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SPMIP9 | DAZAP2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| SPMIP9 | TRIP13 | psi-mi:“MI:0915”(physical association) | 0.780 |
| RBPMS | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SPMIP9 | FAM136A | psi-mi:“MI:0915”(physical association) | 0.620 |
| KRTAP6-2 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.600 |
| SPMIP9 | KPNA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KPNA3 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPMIP9 | CAMK2A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAC14 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP13-2 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATXN1L | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB32 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPMIP9 | PITX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-4 | SPMIP9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPMIP9 | RBFOX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (54): TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid), TEX37 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GTJ6, A0A1B0GUX0, A0A3Q1MT14, A0JNL1, A5PJD8, B9EJX3, E1B9R1, E1BNS6, F1MMV1, Q0P591, Q148A4, Q14BB9, Q1JPL0, Q2KJ10, Q2MH31, Q2T9T0, Q2TA11, Q32L72, Q32L77, Q3V0Q6, Q5BN46, Q5PQN4, Q5RBH3, Q5RHU7, Q5SPV6, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HR9, Q6AYM0, Q7Z5V6, Q8CDU5, Q8N5S3, Q8N865, Q8NA69, Q8NCR6, Q8NEG2, Q95LU0, Q96K30
Diamond homologs: A5PJD8, Q96LM6, Q9DAG4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 45 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 21.8× | 2e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
526 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:88529050:A:AG | acceptor_gain | 0.9900 |
| 2:88529051:G:GG | acceptor_gain | 0.9900 |
| 2:88529051:GC:G | acceptor_gain | 0.9900 |
| 2:88529051:GCA:G | acceptor_gain | 0.9900 |
| 2:88524727:GCG:G | donor_gain | 0.9800 |
| 2:88524770:A:T | donor_gain | 0.9800 |
| 2:88524783:G:GG | donor_gain | 0.9800 |
| 2:88524794:G:GT | donor_gain | 0.9800 |
| 2:88524795:G:T | donor_gain | 0.9800 |
| 2:88526464:G:GT | donor_gain | 0.9800 |
| 2:88526493:AAGAG:A | donor_loss | 0.9800 |
| 2:88526494:AGAG:A | donor_loss | 0.9800 |
| 2:88526495:GAG:G | donor_gain | 0.9800 |
| 2:88526496:AG:A | donor_loss | 0.9800 |
| 2:88526497:GG:G | donor_loss | 0.9800 |
| 2:88526498:GTA:G | donor_loss | 0.9800 |
| 2:88526507:C:T | donor_gain | 0.9800 |
| 2:88529046:CCACA:C | acceptor_loss | 0.9800 |
| 2:88529047:CACAG:C | acceptor_loss | 0.9800 |
| 2:88529048:ACAG:A | acceptor_loss | 0.9800 |
| 2:88529049:CA:C | acceptor_loss | 0.9800 |
| 2:88529050:AGCAG:A | acceptor_gain | 0.9800 |
| 2:88529051:G:A | acceptor_loss | 0.9800 |
| 2:88529051:GCAGG:G | acceptor_gain | 0.9800 |
| 2:88524779:GTCT:G | donor_gain | 0.9700 |
| 2:88526511:C:T | donor_gain | 0.9700 |
| 2:88529048:A:AG | acceptor_gain | 0.9600 |
| 2:88529032:T:G | acceptor_gain | 0.9500 |
| 2:88529049:C:G | acceptor_gain | 0.9400 |
| 2:88524776:GCT:G | donor_gain | 0.9300 |
AlphaMissense
1192 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:88529187:T:C | F86L | 0.943 |
| 2:88529189:C:A | F86L | 0.943 |
| 2:88529189:C:G | F86L | 0.943 |
| 2:88529142:T:C | F71L | 0.894 |
| 2:88529144:C:A | F71L | 0.894 |
| 2:88529144:C:G | F71L | 0.894 |
| 2:88529190:T:C | F87L | 0.890 |
| 2:88529192:C:A | F87L | 0.890 |
| 2:88529192:C:G | F87L | 0.890 |
| 2:88529463:T:C | F178L | 0.889 |
| 2:88529465:T:A | F178L | 0.889 |
| 2:88529465:T:G | F178L | 0.889 |
| 2:88526432:A:C | S19R | 0.862 |
| 2:88526434:C:A | S19R | 0.862 |
| 2:88526434:C:G | S19R | 0.862 |
| 2:88529088:T:C | F53L | 0.840 |
| 2:88529090:T:A | F53L | 0.840 |
| 2:88529090:T:G | F53L | 0.840 |
| 2:88529235:T:C | F102L | 0.794 |
| 2:88529237:C:A | F102L | 0.794 |
| 2:88529237:C:G | F102L | 0.794 |
| 2:88529171:C:A | D80E | 0.788 |
| 2:88529171:C:G | D80E | 0.788 |
| 2:88529447:G:C | W172C | 0.781 |
| 2:88529447:G:T | W172C | 0.781 |
| 2:88529169:G:C | D80H | 0.774 |
| 2:88529074:T:C | L48P | 0.768 |
| 2:88529143:T:C | F71S | 0.768 |
| 2:88529159:G:A | M76I | 0.754 |
| 2:88529159:G:C | M76I | 0.754 |
dbSNP variants (sampled 300 via entrez): RS1000636536 (2:88525105 C>T), RS1001076160 (2:88527844 A>T), RS1001133342 (2:88528095 TATTA>T), RS1001348610 (2:88523272 TAAA>T), RS1001831470 (2:88525741 G>A,C), RS1001993070 (2:88525407 C>G), RS1002134425 (2:88525539 A>G), RS1002380880 (2:88524436 C>CT), RS1004111116 (2:88523101 T>C), RS1004335257 (2:88527231 G>A), RS1004750927 (2:88523013 C>T), RS1004872822 (2:88524120 C>G,T), RS1005338814 (2:88528610 C>T), RS1005406619 (2:88524709 C>A), RS1005491849 (2:88523270 C>T)
Disease associations
OMIM: gene MIM:619676 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 4 |
| Benzo(a)pyrene | increases methylation, increases expression | 2 |
| butyraldehyde | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Magnetite Nanoparticles | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.